glp-1 comparison chart weight loss Is Toujeo a GLP-1? The critical difference explained GLP-1 Weight Loss Tracker Progress

Market Problems Arising Unlike FDA-approved drugs, compounded medications are not subject to the same rigorous testing for safety, quality, and efficacy

In 2025, the MHRA reported the seizure of more than 5,000 illegally traded GLP-1 pens

The win: the Wegovy pill (oral semaglutide 25 mg), launched January 5, 2026, generated $354 million in its first full quarter, doubling analyst estimates

A major meta-analysis finds that patients who discontinue anti-obesity medications quickly regain weight, yet, crucially, they still retain some of their original weight loss a year later, spotlighting the challenges and promise of long-term obesity treatment

The FDA does not review compounded drugs for safety, effectiveness, or quality before marketing